Delivery Order SPE2DB20D3103-SPE2DB23FM4H3
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROVAYBLUE 50 MG/10 ML AMPULE 10ML medical products. The award has a ceiling value of $6,827.92 and a completion date of February 6, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen also holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a pharmaceutical product called PROVAYBLUE 50 MG/10 ML AMPULE 10ML. The contract has a ceiling value of $9,063.19 and a completion date of September 25, 2024. It is a delivery order contract with a firm fixed-price pricing type. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,399.56, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. The IDC enables efficient government procurement of essential pharmaceutical and medical supplies to support military healthcare...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,645.71, is a Firm Fixed Price Delivery Order for the pharmaceutical product "PROVAYBLUE 50 MG/10 ML AMPULE 10ML". The contract has an ultimate completion date of March 4, 2024 and was awarded on March 1, 2024. There is no set-aside designation mentioned for this award....
- This contract award, identified as SPE2DB22D3401|SPE2DB25FT0TB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,319.40 firm-fixed-price delivery order is for the medical product "PROVAYBLUE 50 MG/10 ML AMPULE 10ML" and has a completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML pharmaceutical products. The fixed-price delivery order, valued at $5,973.29, has an ultimate completion date of October 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This contract award, with ID SPE2DX15D2205|SPE2DX24F77TB, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a pharmaceutical product, with a ceiling value of $2,998.77. The contract is a firm fixed-price Delivery Order and does not have a set-aside designation, indicating it was competed on a full and open basis....
- This federal contract award, with ID SPE2DB22D3004|SPE2DB24FRF76, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a pharmaceutical product, with a ceiling value of $4,857.96 and a completion date of August 1, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. Amerisourcebergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,380.14 fixed-price delivery order contract is for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a specialty medication, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,833.18, is for the delivery of PROVAYBLUE 50 MG/10 ML AMPULE 10ML medical supplies. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM4H3Delivery Order
This contract award is for the delivery of the pharmaceutical product "PROVAYBLUE 50 MG/10 ML AMPULE 10ML" to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $61,414.95 and was awarded on February 9, 2023, with a completion date of February 10, 2023. The contract is a delivery order with a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.4k | 2/9/23 |